RT Journal Article
SR Electronic
T1 Adenosine: a new drug for acute termination of supraventricular tachycardia
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 383
OP 388
VO 57
IS 4
A2 Donald G. Vidt
A2 Alan W. Bakst
A1 Sergio L. Pinski
A1 James D. Maloney
YR 1990
UL http://www.ccjm.org/content/57/4/383.abstract
AB Adenosine, recently released for the acute termination of supraventricular tachycardia, is potentially the drug of first choice for this indication. Its notable effects are transient slowing of the sinus rate and atrioventricular nodal block. Adverse effects are transient and clinically insignificant, primarily because of the ultra-short half-life of the drug. Preliminary investigations suggest that adenosine may also be useful in the differential diagnosis of wide Q R S complex tachycardias.